Literature DB >> 14985401

Genetic and epigenetic profile of sporadic pheochromocytomas.

A Cascon1, S Ruiz-Llorente, M F Fraga, R Leton, D Telleria, J Sastre, J Jose Diez, G Martinez Diaz-Guerra, J A Diaz Perez, J Benitez, M Esteller, M Robledo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14985401      PMCID： PMC1735704          DOI： 10.1136/jmg.2003.012658

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  14 in total

Review 1.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

2.  Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.

Authors:  Paraskevi Xekouki; Eva Szarek; Petra Bullova; Alessio Giubellino; Martha Quezado; Spyridon A Mastroyannis; Panagiotis Mastorakos; Christopher A Wassif; Margarita Raygada; Nadia Rentia; Louis Dye; Antony Cougnoux; Deloris Koziol; Maria de La Luz Sierra; Charalampos Lyssikatos; Elena Belyavskaya; Carl Malchoff; Jessica Moline; Charis Eng; Louis James Maher; Karel Pacak; Maya Lodish; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-02-19       Impact factor: 5.958

3.  Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.

Authors:  Hongsai Chen; Weidong Zhu; Xiye Li; Lu Xue; Zhaoyan Wang; Hao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-03       Impact factor: 4.553

Review 4.  Pathological mechanisms and parent-of-origin effects in hereditary paraganglioma/pheochromocytoma (PGL/PCC).

Authors:  Ulrich Müller
Journal:  Neurogenetics       Date:  2011-03-09       Impact factor: 2.660

Review 5.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

Review 6.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

7.  Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.

Authors:  Alexander Weber; Michael M Hoffmann; Hartmut P H Neumann; Zoran Erlic
Journal:  Horm Cancer       Date:  2012-05-10       Impact factor: 3.869

Review 8.  Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?

Authors:  Esther Korpershoek; Karel Pacak; Lucia Martiniova
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

9.  Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.

Authors:  Jean-Pierre Bayley; Ivonne van Minderhout; Marjan M Weiss; Jeroen C Jansen; Peter H N Oomen; Fred H Menko; Barbara Pasini; Barbara Ferrando; Nora Wong; Lesley C Alpert; Rosie Williams; Edward Blair; Peter Devilee; Peter E M Taschner
Journal:  BMC Med Genet       Date:  2006-01-11       Impact factor: 2.103

10.  Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Authors:  Nimrod B Kiss; Andreas Muth; Adam Andreasson; C Christofer Juhlin; Janos Geli; Martin Bäckdahl; Anders Höög; Bo Wängberg; Ola Nilsson; Håkan Ahlman; Catharina Larsson
Journal:  Endocr Relat Cancer       Date:  2013-02-18       Impact factor: 5.678
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.